QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

PACB

QT61Pacific Biosciences of California, Inc.
NASDAQ·Healthcare·Medical - Devices·USA
Latest market price
1.40
+0.06+4.48%
OverviewShort InterestFilings
PACBQT61Pacific Biosciences of California, Inc.·NASDAQ
OverviewShort InterestFilings
1.40+4.48%
TA
Loading chart...
Screen all →
ABT-0.10%$88.41ISRG+1.14%$406.78SYK+2.21%$307.80MDT+1.54%$79.34BSX+0.76%$45.29EW+0.78%$87.36DXCM+1.74%$72.47RMD+1.26%$188.63
Snapshot
Index-P/E-EPS (ttm)
-0.43
Insider Own6.74%
Shs Outstand310.60M
Perf Week3.70%
Market Cap416.21MForward P/E-EPS next Y-0.47Insider Trans-0.26%Shs Float-Perf Month21.74%
Enterprise Value1.06BPEG-EPS next Q-0.13Inst Own-Short Float-Perf Quarter0.00%
Income-130605525.00P/S2.60EPS this Y4.65%Inst Trans-Short Ratio-Perf Half Y-30.69%
Sales160.03MP/B173.20EPS next Y-14.15%ROA-16.43%Short Interest-Perf YTD-25.13%
Book/sh0.01P/C-EPS next 5Y-ROE-488.45%52W High2.73 -48.72%Perf Year7.69%
Cash/sh0.89P/FCF-EPS past 3/5Y-ROIC-22.69%52W Low1.09 28.44%Perf 3Y-
Dividend Est.-EV/EBITDA-9.97Sales past 3/5Y7.72% 15.16%Gross Margin37.08%Volatility4.99% 5.50%Perf 5Y-
Dividend TTM-EV/Sales6.64EPS Y/Y TTM54.21%Oper. Margin-101.72%ATR (14)0.11Perf 10Y-
Dividend Ex-Date-Quick Ratio4.87Sales Y/Y TTM3.90%Profit Margin-80.34%RSI (14)50.38Recom2.56
Dividend Gr. 3/5Y-Current Ratio5.65EPS Q/Q20.00%SMA200.04%Beta2.59Target Price1.00
Payout0.00%Debt/Eq297.29Sales Q/Q0.00%SMA50-3.30%Rel Volume0.71Prev Close1.34
Employees575LT Debt/Eq151.80EarningsFeb 09SMA200-16.79%Avg Volume6.05MPrice1.40
IPO DateOct 27, 2010Option/ShortNo / YesEPS/Sales Surpr.29.41% -7.50%Net Debt/EBITDA-6.07Volume4,315,565Change4.48%
Analyst Ratings
DateActionAnalystRatingTarget
Apr-14-26ReiteratedBarclaysUnderweight$1.50 → $1.00
Mar-06-26DowngradeBarclaysEqual Weight → Underweight
Aug-08-25ReiteratedBernsteinOutperform$1.50 → $1.70
Jun-25-25ReiteratedBarclaysEqual Weight$2.00 → $1.50
Nov-11-24DowngradeUBSBuy → Neutral
Jun-03-24ReiteratedJefferies$4.00
May-13-24ReiteratedPiper SandlerNeutral$7.50 → $2.00
May-10-24ReiteratedBarclaysEqual Weight$2.00
Apr-22-24DowngradeJP MorganOverweight → Neutral
Apr-18-24DowngradeGoldman SachsBuy → Neutral$2.50
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue160160154
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A100109117
Gross Profit605137
Selling, General and Administrative Excl. Other132141175
Research and Development8997135
Other Operating Expense2370202
Operating Income-163-558-474
Interest Expense4713
Unusual Expense
———
Non-Operating Income (Expense)-39-18-178
Net Income Before Taxes-128-546-310
Income Taxes000
Consolidated Net Income-128-546-310
Net Income From Continuing Operations-128-546-310
Net Income-128-546-310
EPS (Recurring)-0.43-1.82-1.13
EPS (Basic, Before Extraordinaries)-0.43-1.82-1.13
EPS (Diluted)-0.43-1.82-1.07
EBITDA-107-34-243
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio2.683.51—
Gross Margin37.5031.8724.03
Operating Margin-101.88-348.75-307.79
Net Margin-80.00-341.25-201.30
Shares Outstanding306300274
Market Capitalization428561—
Operating Lease Expense
———
Insider Trading Volume
$1.47$1.32$1.16$1.00$0.85● Close Price0.00M0.28M0.56M0.84M1.13MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Gibson James R IISee RemarksApr 01 '26Sale1.3788,185120,8131,245,663Apr 03 12:00 AM
HENRY CHRISTIAN OSee RemarksMar 03 '26Sale1.5112,49718,9203,581,813Mar 04 12:00 AM
Van Oene MarkSee RemarksMar 03 '26Sale1.516,5049,8472,243,634Mar 04 12:00 AM
Farmer MicheleSee RemarksMar 03 '26Sale1.512,9794,510305,948Mar 04 12:00 AM
HENRY CHRISTIAN OSee RemarksFeb 18 '26Sale1.63140,874229,4842,673,500Feb 19 12:00 AM
Van Oene MarkSee RemarksFeb 18 '26Sale1.6355,10789,7691,742,638Feb 19 12:00 AM
Farmer MicheleSee RemarksFeb 18 '26Sale1.6314,95224,357219,092Feb 19 12:00 AM
Van Oene MarkSee RemarksFeb 17 '26Sale1.58129,790204,5491,797,745Feb 19 12:00 AM
HENRY CHRISTIAN OSee RemarksFeb 17 '26Sale1.58331,793522,9062,814,374Feb 19 12:00 AM
Farmer MicheleSee RemarksFeb 17 '26Sale1.5835,21555,499234,044Feb 19 12:00 AM
Van Oene MarkSee RemarksAug 18 '25Sale1.3126,83635,1821,920,035Aug 20 12:00 AM
Farmer MicheleSee RemarksMay 19 '25Sale1.005,1955,200269,259May 21 12:00 AM
Farmer MicheleSee RemarksMar 03 '25Sale1.412,9734,183184,619Mar 05 12:00 AM
HENRY CHRISTIAN OSee RemarksMar 03 '25Sale1.4112,49717,5832,225,357Mar 05 12:00 AM
Van Oene MarkSee RemarksMar 03 '25Sale1.416,4869,1261,497,695Mar 05 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR